Ligand Pharmaceuticals (LGND) Q2 2017 Earnings

9MayConfirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
0.39
0.68
0.96
1.25

Details

Expected EPS
0.63
Actual EPS
0.57
Surprise EPS
-0.06
Surprise Percent
+9.52%

Description

Ligand Pharmaceuticals (LGND) has reported earnings of 0.57 per share for Q2 2017.

0 Comments

Share your thoughts